Lifevantage Corporation

Last updated September 27, 2026

Organization details

Legal name
Lifevantage Corporation
Former names
Lifeline Therapeutics, INC. Yaak River Resources Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Headquarters city
Lehi
Headquarters state / province
Utah
Headquarters country
United States
Fiscal year end
June
Ticker symbol
LFVN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000849146
EIN
90-0224471
Wikidata ID
Q7251172

Board of directors

Chief executives

Terrence Moorehead · President and CEO
Since August 2026
Steven R. Fife · President and CEO
Until August 2026 · Former

Director election results

Annual meeting of November 6, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 4 other boards. 2 are in the same sector.

Network of Lifevantage Corporation's board connections FitLife Brands Inc. FitLife Brands Inc. Nature's Sunshine Products Inc. Nature's Sunshine Prod... Optex Systems Holdings Inc. Optex Systems Holdings... Xenia Hotels & Resorts Inc. Xenia Hotels & Resorts... Judd Dayton Judd Dayton Terrence Moorehead Terrence Moorehead Lifevantage Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$195,983
8 purchases by 2 insiders
Sold, last 12 months
$222,086
4 sales by 2 insiders
Date Insider Transaction Shares Price Value
Nov 5, 2026 Rajendran Anbalagan Director Grant or award +17,888 $5.87 $105,003
Nov 5, 2026 Michael A. Beindorff Director Grant or award +17,888 $5.87 $105,003
Nov 5, 2026 Judd Dayton Director Grant or award +17,888 $5.87 $105,003
Nov 5, 2026 Raymond B. Greer Director Grant or award +17,888 $5.87 $105,003
Nov 5, 2026 Darwin Lewis Director Grant or award +17,888 $5.87 $105,003
Oct 7, 2026 Aure Carl Officer (Chief Financial Officer) Grant or award +35,749 — —
Oct 7, 2026 Cunningham Kristen Officer (Chief Sales Officer) Grant or award +32,850 — —
Oct 7, 2026 Terrence Moorehead Director, Officer (President and CEO) Grant or award +193,237 — —
Oct 1, 2026 Aure Carl Officer (Chief Financial Officer) Shares withheld for tax −460 $6.24 $2,870
Oct 1, 2026 Cunningham Kristen Officer (Chief Sales Officer) Shares withheld for tax −637 $6.24 $3,975
Sep 15, 2026 Darwin Lewis Director Open-market purchase +976 $6.22 $6,071
Sep 14, 2026 Cunningham Kristen Officer (Chief Sales Officer) Open-market sale −8,901 $6.18 $55,008
Sep 11, 2026 Cunningham Kristen Officer (Chief Sales Officer) Open-market sale −100 $6.41 $641
Sep 10, 2026 Aure Carl Officer (Chief Financial Officer) Shares withheld for tax −1,869 $6.37 $11,906
Sep 10, 2026 Cunningham Kristen Officer (Chief Sales Officer) Shares withheld for tax −2,254 $6.37 $14,358

Organizations in the same sector, closest in location and size first.

Questions about Lifevantage Corporation

Who is the CEO of Lifevantage Corporation?

Terrence Moorehead has been Lifevantage Corporation's President and CEO since August 2026.

How many directors are on Lifevantage Corporation's board?

Lifevantage Corporation's board has 10 directors: Cynthia Latham, Darwin Lewis, Erin Brockovich, Garry Paul Mauro, Judd Dayton, Michael A. Beindorff, Rajendran Anbalagan, Raymond B. Greer, Steven R. Fife and Terrence Moorehead.

Are Lifevantage Corporation insiders buying or selling shares?

Over the last 12 months, Lifevantage Corporation insiders bought $195,983 of shares in 8 purchases and sold $222,086 of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="lifevantage-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.